Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Syl-View Rehabilitation & Memory Care Center, 411 Pine St, Sylvania, GA 30467, United States

Total all time reports:  1
Latest report: April 21, 2020 12:00 PM
Nursing home show cases of COVID-19, Syl-View Rehabilitation & Memory Care Center, 411 Pine St, Sylvania, GA 30467, United States

Nursing home show cases of COVID-19

April 21, 2020 12:00 PM

“Three residents and one employee tested positive for COVID-19. There are 69 patients total.

Source: wrdw.com See Less
Reported By SafelyHQ.com User

Related Reports

July 13, 2020 12:00 PM

“A Cooper Service employee in Texarkana tests positive for coronavirus

Source: texarkanagazette.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“Four staff members at Shooter's Pub recently tested positive for COVID-19. Any visitor between June 29 and July 6 was possibly exposed to the coronavirus.

Source: rivertowns.net See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Carrabba's Italian Grill, 2832 Washington Rd, Augusta, GA 30909, USA

Carrabba's Italian Grill, 2832 Washington Rd, Augusta, GA 30909, USA

July 13, 2020 12:00 PM

“An employee at Carrabba's Italian Grill on Washington Rd. in Augusta has tested positive for COVID-19. The employee felt fine before a shift at the time but learned of the positive result after.

So ... See Moreurce: wfxg.com See Less
Reported By SafelyHQ.com User

TSA agent test positive for Covid-19, O'Hare International Airport - Terminal 2 Departures, Chicago, IL 60666, USA

O'Hare International Airport - Terminal 2 Departures, Chicago, IL 60666, USA

July 13, 2020 12:00 PM

“A Transportation Security Administration worker at Terminal 2 in O’Hare International Airport has tested positive for COVID-19. The employee last worked Sunday morning.

Source: chicago.cbslocal.com See Less
Reported By SafelyHQ.com User

Employee test positive for Covid-19, Graceway IGA, 102 Leeward Hwy, Venetian Road Settlement TKCA 1ZZ, Turks and Caicos Islands

Graceway IGA, 102 Leeward Hwy, Venetian Road Settlement TKCA 1ZZ, Turks and Caicos Islands

July 13, 2020 12:00 PM

“An employee from Graceway IGA in Turks & Caicos has tested positive for COVID-19.

Source: gracewaysupermarkets.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“At least 70 employees at SFO have tested positive for COVID-19. It is unknown where the infected employees worked at the airport.

Source: sfoconnect.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“Three staff members at Broz Sports Bar & Grill recently tested positive for COVID-19. Anyone who visited the bar between June 25 and June 30 could have been exposed to the the coronavirus.

Source: rivertowns.net See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“I’m so terrified that my dad might have Covid-19. He’s exhibiting all of the symptoms and I’m starting to feel chest pain even though I’ve done nothing but stay inside and keep clean. THE PANDEMIC IS NOT OVER, STAY AT HOME, WEAR A MASK. THIS IS NOT A JOKE. See Less
Reported By SafelyHQ.com User

Six employees test positive for Covid-19, Chattanooga Area Regional Transportation Authority, 1617 Wilcox Blvd, Chattanooga, TN 37406, USA

Chattanooga Area Regional Transportation Authority, 1617 Wilcox Blvd, Chattanooga, TN 37406, USA

July 13, 2020 12:00 PM

“Six Chattanooga Area Regional Transportation Authority employees recently tested positive for COVID-19.

Source: wdef.com See Less
Reported By SafelyHQ.com User

July 13, 2020 12:00 PM

“A crew member at the Sonic in London tested positive for COVID-19 and Several crew members were told to self-quarantining.

Source: wymt.com See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

July 2, 2020 9:00 PM

“Company name: Transliquid Technologies LLC
Brand name: Mystic Shield
Product recalled: Mystic Shield Protection Topical Solution
Reason of the recall: Undeclared methanol
FDA Recall date: July 02, 2020
Recall details: Company Announcement Transliquid Technologies LLC is voluntarily recalling al ... See Morel Mystic Shield Protection Topical Solution, manufactured by Mystic Intl S.A. de C.V in Mexico City, and packaged in an 8.45 ounce (250 ml) bottles, to the consumer level. The firm’s independent testing found the products contain undeclared methanol. Risk Statement: Substantial methanol exposure “could result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidentally ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning.”

To date, Transliquid Technologies LLC has not received any reports of adverse events related to the product in question. The product is an alcohol-based hand sanitizer used to reduce bacteria that potentially cause disease when soap and water are not available and is packaged in an 8.45 ounce (250 ml) blue or green labeled bottle with a white or transparent cap and bears a green or blue label identifying Mystic Shield Protection. The product was distributed between May 21, 2020-June 30, 2020 to select wholesale and retail customers in California, Louisiana, Massachusetts, and Texas.

Transliquid Technologies LLC has accounted for and prevented distribution of a substantial majority of the product at the consumer level and is arranging for its return. Transliquid Technologies LLC is notifying its distributors and customers by email and first-class U.S. Mail and is arranging for the return of all recalled products. Consumers, distributors, and retailers that have Mystic Shield Protection hand sanitizer, which is being recalled, should stop using and return to the place of purchase. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

BLM Protest, Plymouth, MI 48170, USA

Plymouth, MI 48170, USA

June 3, 2020 6:46 PM

“~10,000 people meet up in DOWNTOWN PLYMOUTH, Michigan at the fountain, park, marched the streets, and then city hall/police/fire Dept. started at 2pm...still happening at .7pm. Seems peaceful so far See Less
Reported By SafelyHQ.com User

Hardee's, Army Post Road, Des Moines, IA, USA, Hardee's, Army Post Road, Des Moines, IA, USA

Symptoms: Other
Hardee's, Army Post Road, Des Moines, IA, USA

June 5, 2020 8:07 AM

“Foreign objects in coffee. Looked like burger from nose. See Less
Reported By SafelyHQ.com User

June 29, 2020 2:01 PM

“Company name: UVT, INC.
Brand name: Saniderm
Product recalled: Advanced Hand Sanitizer, 70% alcohol content
Reason of the recall: Potential presence of methanol (wood alcohol)
FDA Recall date: June 29, 2020
Recall details: UVT, INC. is voluntarily recalling 38,830 liters of SANIDERM ADVANCED H ... See MoreAND SANITIZER, packaged in 1-liter bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol) To date, UVT, INC. has not received any reports of adverse events related to this recall.

The affected SANIDERM ADVANCED HAND SANITIZER includes lot number 0530, Expiration date 04/2022. The product can be identified by the label below. The product was distributed Nationwide in the United States. The product is used as a hand sanitizer and is packaged in 1-liter plastic bottles.

Risk Statement: Substantial methanol exposure can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma, permanent damage to the nervous system or death. Although all persons using these products on their hands are at risk, young children who accidently ingest these products and adolescents and adults who drink these products as an alcohol (ethanol) substitute, are most at risk for methanol poisoning.

UVT, INC. is notifying its distributors and customers by phone calls, emails and letter and is arranging for replacement and destruction of all recalled products. Consumers/distributors/retailers that have product which is being recalled should stop using products, initiate recalls to the user level, and return all products to the place of purchase.

Consumers with questions regarding this recall can contact UVT, INC. by phone (951) 427- 3108 or e-mail to customerservice@uvt.world Monday to Friday from 9:00 am and 3:00 pm Pacific Time. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 18, 2020 7:13 PM

“FDA announced the recall of Organic Kudzu Root Herbal Supplement by Mountain Rose Herbs due to the potential to be contaminated with Salmonella. No illnesses have been reported linked to this recall to date.

FDA advises consumers to discard the recalled products or return them to the place of pur ... See Morechase. The product was distributed to customers in the US; and British Columbia, Nova Scotia, Ontario, and Quebec, in Canada.

- Organic Kudzu Root Herbal Supplement. All sizes. Lot # #24247-X / #24247.

Check the full recall on the FDA website fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User
Doctor Visit: Yes
Diagnosis: Salmonella

March 30, 2020 4:04 PM

“This dealerships General Manager, is NOT complying with our City’s mandated Stay Home order. According to manager, dealership is Essential and he already has a sales schedule set out for March 31, 2020 - end of April 2020. This is ridiculous. This type of behavior shows ZERO REGARD for the safety o ... See Moref himself, his family, his employees or their families, including the City of Fresno. This needs to be shut down and definitely reprimanded for actions. See Less
Reported By SafelyHQ.com User

June 1, 2020 6:00 PM

“Company name: Amneal Pharmaceuticals LLC
Brand name: Amneal
Product recalled: Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
Reason of the recall: Due to detection of N-Nitrosodimethylamine (NDMA)
FDA Recall date: June 01, 2020
Recall details: Amneal Pharmaceuticals L ... See MoreLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, within expiry to the Retail Level. Amneal was notified by the U.S. FDA that the Agency’s testing of seven lots of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, showed N-Nitrosodimethylamine (NDMA) amounts above acceptable FDA levels.

FDA recommended the recall of the seven tested lots. Amneal has agreed to this recall and has further decided to extend the recall to all lots within expiry of Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, out of an abundance of caution. Further scientific evaluations are ongoing at Amneal. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall. Amneal’s Metformin Hydrochloride Immediate Release Tablets, USP are not affected by this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant found in water and foods, including meats, dairy products, and vegetables. Metformin HCl Extended-Release Tablets, USP, 500 mg and 750 mg, manufactured by Amneal, are prescription, solid oral products that are indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. The Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, subject to the recall, are identified by the NDC numbers stated on the product label.

Metformin HCl Extended-Release Tablets, USP, 500 mg
53746-178-01. 100 count bottles
53746-178-05. 500 count bottles
53746-178-10. 1000 count bottles
53746-178-90. 90 count bottles
53746-178-Bulk. Bulk Box
65162-178-09. 90 count bottles
65162-178-10. 100 count bottles
65162-178-11. 1000 count bottles
65162-178-50. 500 count bottles

Metformin HCl Extended-Release Tablets, USP, 750 mg
53746-179-01. 1000 count bottles
53746-179-Bulk. Bulk Box
65162-179-10. 100 count bottles

The affected Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg and 750 mg, lots were distributed nationwide in the US directly to Wholesalers, Distributors, Retailers, and Repackagers.

Amneal is notifying its direct customers via mail (UPS Standard Overnight) by mailing a recall notification letter and is arranging for the return of all the recalled products. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

Bike Protest, Williamsburg Bridge, Brooklyn, NY, USA

Williamsburg Bridge, Brooklyn, NY, USA

June 13, 2020 12:40 PM

“Peaceful protest from Manhattan to Brooklyn See Less
Reported By SafelyHQ.com User

July 7, 2020 3:00 PM

“Company name: Mylan Institutional LLC
Brand name: Mylan
Product recalled: Daptomycin for Injection
Reason of the recall: Presence of particulate matter
FDA Recall date: July 07, 2020
Recall details: Mylan N.V. (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is ... See Moreconducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial due to the presence of particulate matter found in one single-dose vial manufactured by Mylan Laboratories Limited’s Specialty Formulation Facility. To date, Mylan has not received any reports of adverse events related to this recall.

Intravenous administration of a solution containing visible particulates could lead to serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism. This batch was distributed nationwide to wholesalers and retail pharmacies between April 2020 and May 2020. The recalled batch is as follows:

- NDC #: 67457-813-50
- Material Description: Daptomycin for Injection
- Strength: 500 mg/vial
- Size: 20 mL vial
- Lot No: 7605112
- Expiry: October 2021

Daptomycin for injection is an injectable antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bloodstream infections (bacteremia) in adult patients.

Mylan is notifying its distributors and customers by letter and is arranging for return of all recalled products. Consumers/distributors/retailers that have product which is being recalled should stop use/further distribution or dispensing.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

May 22, 2020 4:00 PM

“Company name: Acella Pharmaceuticals, LLC
Brand name: Acella
Product recalled: 30-mg, 60-mg and 90-mg NP Thyroid®
Reason of the recall: Super potency
FDA Recall date: May 22, 2020
Recall details: Company Announcement Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30 ... See More-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. The products are being recalled because our testing has found these lots to be superpotent. The product may have up to 115.0% of the labeled amount of Liothyronine (T3). Risk Statement: Patients being treated for hypothyroidism (underactive thyroid), who receive superpotent NP Thyroid, may experience signs and symptoms of hyperthyroidism (overactive thyroid) which include, but are not limited to, weight loss, heat intolerance, fatigue, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances. Pregnant women who take superpotent NP Thyroid may also experience negative maternal and fetal outcomes including miscarriage and/or impairment to fetal development. Patients should talk to their healthcare professional before they stop taking their NP Thyroid medicine. To date, Acella has received two reports of adverse events known to be related to this recall. NP Thyroid (thyroid tablets, USP) is composed of levothyroxine and liothyronine, and used to treat hypothyroidism (underactive thyroid). The products subject to recall are packed in 100-count bottles. See product images. To best identify the product, the NDC’s, Product Description, Lot Numbers and Expiration Dates are listed. These lots were distributed nationwide in the USA to Acella’s direct accounts.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User